OncoLink Controversy

I read the article "Struggle Over Online Cancer Service Spurs Larger Medical Ethics Debate" (F. Hoke, The Scientist, April 3, 1995, page 1) with great interest. My strongly felt opinion is that Loren Buhle has been pivotal in creating an extremely useful resource for cancer patients and their families, as well as for the medical community at large. It is distressing to see that he has been relieved of his responsibilities as a result of the University of Pennsylvania's desire to filter informat

Written byNick Busigin
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I read the article "Struggle Over Online Cancer Service Spurs Larger Medical Ethics Debate" (F. Hoke, The Scientist, April 3, 1995, page 1) with great interest.

My strongly felt opinion is that Loren Buhle has been pivotal in creating an extremely useful resource for cancer patients and their families, as well as for the medical community at large. It is distressing to see that he has been relieved of his responsibilities as a result of the University of Pennsylvania's desire to filter information. When will the medical community learn that the public does not want a medical priesthood that reserves information for the initiated? I fully support Buhle in his efforts to provide an open forum for the exchange of information on cancer.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies